# Ivacaftor for Acquired CFTR Dysfunction in Chronic Rhinosinusitis

> **NCT03439865** · EARLY_PHASE1 · RECRUITING · sponsor: **University of Alabama at Birmingham** · enrollment: 20 (estimated)

## Conditions studied

- Chronic Rhinosinusitis (Diagnosis)

## Interventions

- **DRUG:** Ivacaftor
- **DRUG:** standard of care treatment

## Key facts

- **NCT ID:** NCT03439865
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-05-02
- **Primary completion:** 2027-04
- **Final completion:** 2027-05-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-04-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03439865

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03439865, "Ivacaftor for Acquired CFTR Dysfunction in Chronic Rhinosinusitis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03439865. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*